Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775167 | 0.89 | MAPT (0.33) | DYRK1AMAPTKDM4EALDH1A1GAA | |
| SCHEMBL2589556 | 0.88 | TSHR (0.38) | MAPTKDM4EALDH1A1GAAHTT | |
| SCHEMBL12036433 | 0.87 | MAPT (0.32) | DYRK1AMAPTKDM4EALDH1A1GAA | |
| SCHEMBL20371351 | 0.86 | — | — | |
| SCHEMBL15277885 | 0.86 | GPR35 (0.32) | MAPTALDH1A1GAAHTTL3MBTL1 | |
| SCHEMBL12036432 | 0.85 | MAPT (0.31) | DYRK1AMAPTKDM4EALDH1A1GAA | |
| SCHEMBL13262294 | 0.82 | ADORA2A (0.34) | MAPTADORA2AADORA1 | |
| SCHEMBL15281125 | 0.82 | MAPT (0.34) | DYRK1AMAPTKDM4EALDH1A1GAA | |
| SCHEMBL15447923 | 0.78 | ADORA3 (0.32) | ADORA2AADORA1 | |
| SCHEMBL10733659 | 0.78 | CYP1A2 (0.35) | MAPTKDM4EALDH1A1GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227475-A1 | Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component | NATIONAL TSING HUA UNIVERSITY (TW) | 2023-07-20 | — | — | US | disclosed |
| WO-2023106404-A1 | POLYMER COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | 国立大学法人大阪大学 | 2023-06-15 | — | — | WO | disclosed |
| WO-2022090522-A1 | POLYMER | CAMBRIDGE DISPLAY TECHNOLOGY LTD (GB) | 2022-05-05 | — | — | WO | disclosed |
| EP-3626716-A1 | ANTIVIRAL COMPOUNDS | Gilead Pharmasset LLC (US) | 2020-03-25 | — | — | EP | disclosed |
| US-20190036029-A1 | ORGANIC THIN FILM TRANSISTOR ELEMENT, ORGANIC SEMICONDUCTOR FILM-FORMING COMPOSITION, METHOD OF FORMING ORGANIC SEMICONDUCTOR FILM, AND ORGANIC SEMICONDUCTOR FILM | FUJIFILM CORPORATION (JP) | 2019-01-31 | — | — | US | disclosed |
| EP-3346504-A1 | ORGANIC THIN-FILM TRANSISTOR, ORGANIC THIN-FILM TRANSISTOR MANUFACTURING METHOD, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, AND ORGANIC SEMICONDUCTOR FILM MANUFACTURING METHOD | FUJIFILM Corporation (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-9981955-B2 | Antiviral compounds | GILEAD PHARMASSET LLC (US) | 2018-05-29 | — | — | US | disclosed |
| US-20180145258-A1 | ORGANIC SEMICONDUCTOR ELEMENT, COMPOUND, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, AND MANUFACTURING METHOD THEREOF | FUJIFILM CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20180145259-A1 | ORGANIC SEMICONDUCTOR ELEMENT, COMPOUND, ORGANIC SEMICONDUCTOR COMPOSITION, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR FILM | FUJIFILM CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
| US-20110086994-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | XEROX CORPORATION (US) | 2011-04-14 | — | — | US | disclosed |
| WO-2011028827-A2 | ORGANIC ELECTRONIC DEVICES AND POLYMERS, INCLUDING PHOTOVOLTAIC CELLS AND DIKETONE-BASED POLYMERS | PLEXTRONICS, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011028827-A2 | ORGANIC ELECTRONIC DEVICES AND POLYMERS, INCLUDING PHOTOVOLTAIC CELLS AND DIKETONE-BASED POLYMERS | PLEXTRONICS, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| WO-2011028829-A2 | ORGANIC ELECTRONIC DEVICES AND POLYMERS, INCLUDING PHOTOVOLTAIC CELLS AND DIKETONE-BASED AND DIKETOPYRROLOPYRROLE-BASED POLYMERS | PLEXTRONICS, INC. (US) | 2011-03-10 | — | — | WO | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2010-12-09 | — | — | US | disclosed |
| US-20100307594-A1 | Conjugated Polymers and Their Use in Optoelectronic Devices | RAYNERGY TEK INC. (TW) | 2010-12-09 | — | — | US | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
| WO-2010132601-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-11-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230227475-A1 | Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component | AHR, STS, HAT1 | DYRK1A 1818/4885MAPT 4454/4885KDM4E 1870/4885 |
| US-20110086994-A1 | METHODS FOR PREPARING BENZODITHIOPHENES | TST, TPST2, MPST | DYRK1A 1791/4885MAPT 847/4885KDM4E 312/4885 |
| US-20100310512-A1 | ANTIVIRAL COMPOUNDS | MAVS, EIF2AK2, ZC3HAV1 | DYRK1A 4823/4885MAPT 2923/4885KDM4E 2496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.